Retraction notice to “Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects” [Biomedicine & Pharmacotherapy 176 (2024) 116833]

IF 7.5 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Biomedicine & Pharmacotherapy Pub Date : 2026-04-01 Epub Date: 2026-03-07 DOI:10.1016/j.biopha.2026.119193

Mohammad Ebrahimnezhad , Amir Valizadeh , Maryam Majidinia , Peyman Tabnak , Bahman Yousefi

引用次数: 0

查看原文本刊更多论文

“揭示FOXO3在肺癌中的潜力：从分子洞察到治疗前景”[生物医学与药物治疗176(2024)116833]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biomedicine & Pharmacotherapy 医学-药学

CiteScore

11.90

自引率

2.70%

发文量

1621

审稿时长

48 days

期刊介绍： Biomedicine & Pharmacotherapy stands as a multidisciplinary journal, presenting a spectrum of original research reports, reviews, and communications in the realms of clinical and basic medicine, as well as pharmacology. The journal spans various fields, including Cancer, Nutriceutics, Neurodegenerative, Cardiac, and Infectious Diseases.